Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
13,303 total articles
Tempest Therapeutics announced clinical updates from its ongoing Phase 1 trials of TPST-2003, a dual-targeting CD19/BCMA CAR-T therapy. The updated data show a 100% complete response rate among 15 CAR-T-naïve efficacy evaluable patients treated in the REDEEM-1 and POEMS-1 trials for relapsed/refractory multiple myeloma and POEMS syndrome, respectiv…
Madrigal Pharmaceuticals announced first-quarter 2026 financial results demonstrating a 127% year-over-year increase in net sales of its key drug Rezdiffra, reaching $311.3 million. The company highlighted strong patient adoption, with over 42,250 patients on Rezdiffra, and expanded its pipeline through a global licensing agreement for a clinical-s…
Tonix Pharmaceuticals announced an agreement with a major group purchasing organization to provide commercial payer coverage for TONMYA® (cyclobenzaprine HCl sublingual tablets), a first-in-class FDA-approved non-opioid treatment for fibromyalgia in adults. The agreement grants access to around 35 million commercial lives in the U.S., representing …
U.S. Energy Corp. (NASDAQ: USEG) has been selected to participate in the inaugural Emerging Company Pavilion at the 31st Annual Sohn Investment Conference on May 12, 2026. This selection recognizes the company's growth trajectory and market potential, offering exposure to leading institutional investors and enhancing its profile in helium, carbon m…
KVH Industries announced its Q1 2026 results with revenues up 27% year-over-year to $32.3 million, driven primarily by a 30% increase in service revenue led by growth in low Earth orbit (LEO) satellite service sales from Starlink and OneWeb. The company reported a net income of $0.6 million, compared to a loss in the prior year period, and a substa…
Sprott Inc. reported a 9% increase in Assets Under Management (AUM) to $65.1 billion for Q1 2026, driven by market appreciation and net inflows, especially in precious metals and critical materials funds. Revenues and net income significantly increased compared to Q1 2025, supported by higher management fees, carried interest, and ETF expansion, in…
Geron Corporation announced an 8% increase in net revenue for its approved blood cancer drug RYTELO in Q1 2026 compared to Q4 2025, driven by higher demand and expanded ordering accounts. The company reaffirmed its 2026 revenue and expense guidance, highlighted progress in European commercial strategy and clinical trials, and strengthened its leade…
Kymera Therapeutics, a clinical-stage biotech company focused on targeted protein degradation therapies for immunological diseases, announced participation in two upcoming investor conferences in May 2026. The company will hold fireside chats at the Bank of America and RBC Capital Markets healthcare conferences, with live webcasts available on thei…
Energous Corporation, a Nasdaq-listed leader in over-the-air wireless power networks, announced its participation in a fireside chat at Planet MicroCap Las Vegas 2026. The event will feature key executives discussing the company’s strategy and growth, providing an opportunity for investor engagement and visibility in the microcap community.
BioCryst Pharmaceuticals announced its first quarter 2026 financial results highlighting an 11% year-over-year increase in net revenue for ORLADEYO to $148.3 million. The company also revealed a $70 million upfront licensing agreement with Neopharmed Gentili for the European commercial rights to navenibart, with potential milestone payments up to $…
EyePoint, Inc. announced its first quarter 2026 financial results highlighting ongoing Phase 3 clinical trials for its lead product candidate DURAVYU in wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). The company expects topline data for wet AMD trials starting mid-2026 and anticipates completing enrollment for DME …
Immunocore Holdings plc reported a 14% year-over-year increase in Q1 2026 net sales of its lead product, KIMMTRAK, reaching $106.7 million globally. Landmark five-year survival data presented at AACR 2026 demonstrated that KIMMTRAK doubles the likelihood of survival in metastatic uveal melanoma patients. The company is progressing multiple Phase 3 …
Marex Group plc, listed on Nasdaq under the ticker MRX, announced record financial results for Q1 2026, highlighting substantial revenue and profit growth across all business segments. The diversified financial services firm benefited from elevated market volatility, strong client demand, and strategic acquisitions, leading to a 48% increase in rev…
Kamada Ltd., a global biopharmaceutical company specializing in plasma-derived therapies, announced it will release its first quarter 2026 financial results on May 13, 2026, prior to U.S. market open. Management will host a conference call to discuss these results and provide updates on the company's operations and growth strategies.
TScan Therapeutics reported Q1 2026 financial results along with a major corporate update highlighting important upcoming milestones. The company plans initiation of a Phase 3 study for its lead TCR-T therapy candidate TSC-101 in Q2 2026 and expects early data from the ALLOHA Phase 1 trial. Further, Phase 1 studies for new candidates TSC-102-A01 an…
Steven Madden, Ltd. announced first quarter 2026 results with an 18% revenue increase driven by strong brand momentum and direct-to-consumer growth. The company raised its fiscal 2026 revenue guidance to a 10-12% increase and introduced earnings per share guidance between $2.55 and $2.65, signaling confidence in top- and bottom-line growth despite …
Natural Resource Partners L.P. released its first quarter 2026 financial results, highlighting $19.6 million in net income and declaring a $0.75 per common unit distribution. The company generated $33.8 million in free cash flow before a $39.2 million investment in its soda ash business. Though facing headwinds from weak coal sales volumes and over…
Brazil Potash Corp. has awarded the Front-End Engineering Design (FEED) contract for critical surface facilities and infrastructure of its Autazes potash project in Amazonas, Brazil to a consortium of Wood and Promon Engenharia. This milestone is essential for securing construction debt financing from Development Finance Institutions and Export Cre…
eGain Corporation, a leader in AI-powered knowledge management for enterprise customer service, announced it will release its fiscal 2026 third quarter financial results after market close on May 14, 2026, followed by a conference call and webcast hosted by its CEO and CFO.
Apollo Global Management, Inc. announced strong financial results for the first quarter of 2026, highlighting record fee-related earnings and assets under management exceeding $1 trillion. The company declared cash dividends on its common and mandatory convertible preferred stock, reflecting confidence in its financial performance. Apollo continues…
Amaze Holdings announces a strategic partnership with All Media Solutions to support the rollout of Amaze Live, a multi-channel live shopping platform. The partnership grants Amaze immediate access to a broad portfolio of consumer brands, enabling creators to participate in live, shoppable broadcasts starting May 15, 2026, across beauty, wellness, …
Bimergen Energy Corporation has selected SMA as the inverter supplier for its eight recently acquired 9.9 MW battery energy storage system (BESS) projects in the ERCOT market, totaling approximately 80 MW of capacity. This strategic partnership supports compliance with Inflation Reduction Act requirements, enhances project financeability, and marks…
Recursion Pharmaceuticals reported strong first quarter 2026 results marked by milestones including favorable safety and pharmacokinetic data for REC-1245, initiation of dosing in REC-4539, and encouraging Phase 2 efficacy signals in REC-4881 with ongoing FDA engagement. The company highlighted operational efficiencies reducing cash burn and mainta…
Freshpet, Inc. reported robust Q1 2026 financial results with net sales increasing 13.1% year-over-year to $297.6 million, alongside improvements in gross margins and a net income turnaround to $48.5 million from a prior year loss. The company raised its full-year 2026 net sales growth guidance to 8-11%, maintaining Adjusted EBITDA and capital expe…
MannKind Corporation announced the development of a dry powder inhalation (DPI) formulation of ralinepag in partnership with United Therapeutics. The program, supported by a recent $5 million payment from United Therapeutics, aims at treating pulmonary arterial hypertension (PAH) and other fibrotic lung diseases including PH-ILD, IPF, and PPF. The …
